DK1416278T3 - Fremgangsmåder til forbedret diagnosticering af dysplasier - Google Patents
Fremgangsmåder til forbedret diagnosticering af dysplasierInfo
- Publication number
- DK1416278T3 DK1416278T3 DK02024030T DK02024030T DK1416278T3 DK 1416278 T3 DK1416278 T3 DK 1416278T3 DK 02024030 T DK02024030 T DK 02024030T DK 02024030 T DK02024030 T DK 02024030T DK 1416278 T3 DK1416278 T3 DK 1416278T3
- Authority
- DK
- Denmark
- Prior art keywords
- expression
- marker
- cell
- over
- dysplastic
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 206010058314 Dysplasia Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 239000003550 marker Substances 0.000 abstract 11
- 230000014509 gene expression Effects 0.000 abstract 5
- 230000002018 overexpression Effects 0.000 abstract 5
- 101000733249 Homo sapiens Tumor suppressor ARF Proteins 0.000 abstract 4
- 230000004663 cell proliferation Effects 0.000 abstract 4
- 230000006907 apoptotic process Effects 0.000 abstract 2
- 239000012472 biological sample Substances 0.000 abstract 2
- 230000004186 co-expression Effects 0.000 abstract 2
- 230000009758 senescence Effects 0.000 abstract 2
- 102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 abstract 1
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 230000025084 cell cycle arrest Effects 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000002380 cytological effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 238000012956 testing procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Lock And Its Accessories (AREA)
- Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02024030A EP1416278B1 (en) | 2002-10-28 | 2002-10-28 | Method for improved diagnosis of dysplasias |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1416278T3 true DK1416278T3 (da) | 2005-03-21 |
Family
ID=32087956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02024030T DK1416278T3 (da) | 2002-10-28 | 2002-10-28 | Fremgangsmåder til forbedret diagnosticering af dysplasier |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1416278B1 (da) |
| AT (1) | ATE283484T1 (da) |
| DE (1) | DE60202081T2 (da) |
| DK (1) | DK1416278T3 (da) |
| ES (1) | ES2231633T3 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8060348B2 (en) | 2006-08-07 | 2011-11-15 | General Electric Company | Systems for analyzing tissue samples |
| US8131476B2 (en) | 2006-08-07 | 2012-03-06 | General Electric Company | System and method for co-registering multi-channel images of a tissue micro array |
| EP2224244A1 (en) * | 2009-02-26 | 2010-09-01 | Universität des Saarlandes | A diagnostic in-vitro method or assay for diagnosing chronic obstructive pulmonary disease (COPD) |
| US9315848B2 (en) | 2010-08-18 | 2016-04-19 | Technion Research And Development Foundation Ltd. | Volatile organic compounds for detecting cell dysplasia and genetic alterations associated with lung cancer |
| CN109969079B (zh) * | 2019-03-05 | 2022-02-22 | 天津博顿电子有限公司 | 一种新能源汽车警示行人的装置 |
-
2002
- 2002-10-28 DE DE60202081T patent/DE60202081T2/de not_active Expired - Lifetime
- 2002-10-28 AT AT02024030T patent/ATE283484T1/de not_active IP Right Cessation
- 2002-10-28 EP EP02024030A patent/EP1416278B1/en not_active Expired - Lifetime
- 2002-10-28 DK DK02024030T patent/DK1416278T3/da active
- 2002-10-28 ES ES02024030T patent/ES2231633T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1416278B1 (en) | 2004-11-24 |
| DE60202081D1 (de) | 2004-12-30 |
| ATE283484T1 (de) | 2004-12-15 |
| ES2231633T3 (es) | 2005-05-16 |
| EP1416278A1 (en) | 2004-05-06 |
| DE60202081T2 (de) | 2005-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rodier | Detection of the senescence-associated secretory phenotype (SASP) | |
| NZ593226A (en) | Gene expression markers (efnb2) for colorectal cancer prognosis | |
| Laugsand et al. | DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples | |
| PT1217377E (pt) | Processo para a detecção específica de células de tumores e dos seus precursores em colheitas no colo do útero por medição simultânea de pelo menos dois marcadores moleculares diferentes | |
| NO20070598L (no) | Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem | |
| MX2008009592A (es) | Metodos y composiciones para identificar pacientes con una probabilidad incrementada de tener cancer de ovario. | |
| MX2010010465A (es) | Metodo para la deteccion de igf1r/chr 15 en celulas tumorales circulantes mediante hibridacion fluorescente in situ. | |
| Rugge et al. | Individual risk stratification of gastric cancer: evolving concepts and their impact on clinical practice | |
| Journe et al. | TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome | |
| WO2006071903A3 (en) | Cell based methods and systems for the identification of rna regulatory sequences and compounds that modulate their functions | |
| DE60315715D1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| Zou et al. | Synchronous screening of multiplexed biomarkers of Alzheimer's disease by a length-encoded aerolysin nanopore-integrated triple-helix molecular switch | |
| US11035858B2 (en) | Methods of isolating barrel-like proteases and identifying peptides processed thereby | |
| Ancin et al. | The correlation of serum sPD-1 and sPD-L1 levels with clinical, pathological characteristics and lymph node metastasis in nonsmall cell lung cancer patients | |
| Lieschke et al. | Flow cytometric single cell-based assay to simultaneously detect cell death, cell cycling, DNA content and cell senescence | |
| Bührens et al. | Protein expression in human non-small cell lung cancer: a systematic database | |
| DE60325541D1 (de) | Verfahren/Präparat zur Erkennung von Pankreaskrebs | |
| DK1416278T3 (da) | Fremgangsmåder til forbedret diagnosticering af dysplasier | |
| SG11201811433TA (en) | Mmp1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method | |
| Mossberg et al. | A direct electrochemical detection method of melanoma based on melanoma biomarker | |
| Yan et al. | Cofilin immunolabelling correlates with depth of invasion in gastrointestinal endocrine cell tumors | |
| Vergel et al. | Bypassing cellular senescence by genetic screening tools | |
| FR2786787B1 (fr) | Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques | |
| CN114428172A (zh) | 用于预测结直肠癌患者术后远处转移风险的标志物及其应用 | |
| WO2007071829A3 (en) | Methods and means related to diseases |